Skip to content

Treatment of female urinary tract infection with faecal bacteria transplantation

Treatment of female urinary tract infection with faecal bacteria transplantation

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045775
Enrollment
Unknown
Registered
2021-04-24
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women's urinary tract infection

Interventions

Sponsors

Affiliated Wuxi No.2 Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria for urinary tract infection group: 1.Aged >=18 years;In addition, urinary tract infections >= 3 times in the last 1 year / >=2 times in the last 6 months, and current urinary tract infections occurred.The diagnostic criteria for urinary tract infection were as follows: urinary culture of the same colony >=10^3 cfu /mL, urine analysis WBC>=10/mm^3;Urinary tract irritations such as frequent urination, urgent urination, dysuria or tenderness in the lower abdomen or buckling pain in the kidney area, with or without fever; 2.Volunteer to participate in the study; 3.Clear consciousness; 4.Able to conduct normal language communication. Inclusion criteria for healthy control group: 1.No urinary tract infection in recent 1 month; 2.Perfect match with the patient group in terms of age (5 years for one segment), sex, marriage, and menstruation. Inclusion criteria for bacteria donors: 1.No history of allergy, long-term medication history, and recent bowel movements; 2.The supplier of faecal bacteria is usually the immediate family member of the recipient; 3.Healthy adults without underlying diseases are excluded from infectious diseases, autoimmune diseases, parasitic infections and other diseases.

Exclusion criteria

Exclusion criteria: Exclusion criteria for urinary tract infection group: 1.Current patients receiving indwelling catheterization; 2.Used antibiotics in the past 1 week; 3.Have used probiotics or synbiotics in the past 1 month; 4.Has the following situation: interstitial cystitis, fever, acute or chronic pyelonephritis, acute or chronic prostate, urethritis, epididymitis, urinary incontinence, urinary tract malformation, bladder neck, hydronephrosis, renal atrophy, neuropathic bladder inflammation, tuberculosis, pregnancy, menstrual period, lactation, serious cardiovascular, liver, kidney disease, mental disorder. Exclusion criteria for healthy control group: 1.Current patients receiving indwelling catheterization; 2.Used antibiotics in the past 1 week; 3.Have used probiotics or synbiotics in the past 1 month; 4.Has the following situation: interstitial cystitis, fever, acute or chronic pyelonephritis, acute or chronic prostate, urethritis, epididymitis, urinary incontinence, urinary tract malformation, bladder neck, hydronephrosis, renal atrophy, neuropathic bladder inflammation, tuberculosis, pregnancy, menstrual period, lactation, serious cardiovascular, liver, kidney disease, mental disorder.

Design outcomes

Primary

MeasureTime frame
glycosylated hemoglobin;renal function;S - creatinine;C reactive protein;blood lipid level;estrogen;endotoxin;CD3 and CD4;the IgA of urine;the IgA of blood;urine analysis;urine culture;

Countries

China

Contacts

Public ContactFeng Ninghan

Affiliated Wuxi No.2 Hospital of Nanjing Medical University

fnh888@njmu.edu.cn+86 13813952696

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026